Status:
COMPLETED
Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
Lead Sponsor:
Institute of Child Health
Collaborating Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust
Conditions:
Ataxia Telangiectasia (AT)
Eligibility:
All Genders
2+ years
Phase:
PHASE3
Brief Summary
Ataxia Telangiectasia (AT) is an autosomal recessive inherited condition caused by mutations in the ATM gene1. Patients suffer from neuro-degenerative problems, usually commencing in the second year o...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Genetically confirmed diagnosis of AT
Exclusion
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00656409
Start Date
June 1 2006
End Date
March 1 2008
Last Update
April 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Great Ormond Street Hospital
London, United Kingdom, WC1N 3JH